Go Pro

SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$5.09 +0.02 (+0.39%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$5.05 -0.04 (-0.81%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBC vs. PGNY, ASTH, AGL, PNTG, and AMN

Should you buy SBC Medical Group stock or one of its competitors? SBC Medical Group's main competitors and comparable companies include Progyny (PGNY), Astrana Health (ASTH), Agilon Health (AGL), The Pennant Group (PNTG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does SBC Medical Group compare to Progyny?

Progyny (NASDAQ:PGNY) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Progyny has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

94.9% of Progyny shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 9.9% of Progyny shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SBC Medical Group has a net margin of 27.99% compared to Progyny's net margin of 6.00%. SBC Medical Group's return on equity of 18.47% beat Progyny's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny6.00% 15.98% 10.65%
SBC Medical Group 27.99%18.47%13.10%

Progyny has higher revenue and earnings than SBC Medical Group. SBC Medical Group is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$1.29B1.50$58.52M$0.9227.42
SBC Medical Group$173.61M3.02$50.99M$0.4710.83

In the previous week, Progyny had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 6 mentions for Progyny and 4 mentions for SBC Medical Group. Progyny's average media sentiment score of 0.84 beat SBC Medical Group's score of 0.19 indicating that Progyny is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Progyny presently has a consensus price target of $34.36, indicating a potential upside of 36.20%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 66.99%. Given SBC Medical Group's higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Progyny.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.85
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Progyny beats SBC Medical Group on 11 of the 17 factors compared between the two stocks.

How does SBC Medical Group compare to Astrana Health?

SBC Medical Group (NASDAQ:SBC) and Astrana Health (NASDAQ:ASTH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

SBC Medical Group has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Astrana Health has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market.

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 66.99%. Astrana Health has a consensus price target of $49.88, suggesting a potential upside of 39.01%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80

SBC Medical Group has higher earnings, but lower revenue than Astrana Health. SBC Medical Group is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M3.02$50.99M$0.4710.83
Astrana Health$3.18B0.63$22.49M$0.8243.76

SBC Medical Group has a net margin of 27.99% compared to Astrana Health's net margin of 1.05%. SBC Medical Group's return on equity of 18.47% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Astrana Health 1.05%10.30%3.67%

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, SBC Medical Group and SBC Medical Group both had 4 articles in the media. SBC Medical Group's average media sentiment score of 0.19 beat Astrana Health's score of 0.11 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Astrana Health
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

SBC Medical Group beats Astrana Health on 9 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Agilon Health?

SBC Medical Group (NASDAQ:SBC) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

60.8% of SBC Medical Group shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by insiders. Comparatively, 2.5% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

SBC Medical Group has a net margin of 27.99% compared to Agilon Health's net margin of -3.92%. SBC Medical Group's return on equity of 18.47% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Agilon Health -3.92%-119.38%-16.85%

In the previous week, SBC Medical Group had 2 more articles in the media than Agilon Health. MarketBeat recorded 4 mentions for SBC Medical Group and 2 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.42 beat SBC Medical Group's score of 0.19 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilon Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SBC Medical Group has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market. Comparatively, Agilon Health has a beta of 2.98, suggesting that its stock price is 198% more volatile than the broader market.

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 66.99%. Agilon Health has a consensus price target of $102.25, suggesting a potential upside of 21.06%. Given SBC Medical Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe SBC Medical Group is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.27

SBC Medical Group has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M3.02$50.99M$0.4710.83
Agilon Health$5.93B0.24-$391.35M-$14.27N/A

Summary

SBC Medical Group beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to The Pennant Group?

The Pennant Group (NASDAQ:PNTG) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

The Pennant Group presently has a consensus price target of $41.60, suggesting a potential upside of 6.01%. SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 66.99%. Given SBC Medical Group's higher possible upside, analysts clearly believe SBC Medical Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

SBC Medical Group has lower revenue, but higher earnings than The Pennant Group. SBC Medical Group is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$947.71M1.45$29.58M$0.9043.60
SBC Medical Group$173.61M3.02$50.99M$0.4710.83

The Pennant Group has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, SBC Medical Group had 2 more articles in the media than The Pennant Group. MarketBeat recorded 4 mentions for SBC Medical Group and 2 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.34 beat SBC Medical Group's score of 0.19 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SBC Medical Group has a net margin of 27.99% compared to The Pennant Group's net margin of 2.93%. SBC Medical Group's return on equity of 18.47% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
SBC Medical Group 27.99%18.47%13.10%

Summary

The Pennant Group and SBC Medical Group tied by winning 8 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

AMN Healthcare Services has a beta of 0.4, meaning that its share price is 60% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

AMN Healthcare Services currently has a consensus target price of $36.00, indicating a potential downside of 1.95%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 66.99%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
SBC Medical Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, SBC Medical Group had 1 more articles in the media than AMN Healthcare Services. MarketBeat recorded 4 mentions for SBC Medical Group and 3 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat SBC Medical Group's score of 0.19 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SBC Medical Group has a net margin of 27.99% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat SBC Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
SBC Medical Group 27.99%18.47%13.10%

SBC Medical Group has lower revenue, but higher earnings than AMN Healthcare Services. SBC Medical Group is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.52-$95.70M$2.6813.70
SBC Medical Group$173.61M3.02$50.99M$0.4710.83

Summary

SBC Medical Group beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$523.49M$9.59B$7.14B$13.17B
Dividend YieldN/A2.61%2.53%16.78%
P/E Ratio10.8334.21275.6826.04
Price / Sales2.995.39662.25102.14
Price / Cash9.69120.5977.6051.75
Price / Book1.985.1510.936.31
Net Income$50.99M$315.68M$3.51B$362.16M
7 Day Performance3.88%-2.59%-2.00%-1.66%
1 Month Performance18.93%-3.19%-6.15%-4.50%
1 Year Performance20.33%7.93%7.44%2.06%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
3.9876 of 5 stars
$5.09
+0.4%
$8.50
+67.0%
+20.3%$523.49M$175.17M10.83863
PGNY
Progyny
4.3483 of 5 stars
$25.70
-2.1%
$34.36
+33.7%
+22.8%$1.97B$1.29B27.93856
ASTH
Astrana Health
3.3806 of 5 stars
$33.09
-5.8%
$49.88
+50.7%
+29.2%$1.85B$3.18B40.383,000
AGL
Agilon Health
1.8516 of 5 stars
$85.21
-1.9%
$102.25
+20.0%
+211.4%$1.43B$5.93BN/A856
PNTG
The Pennant Group
2.6788 of 5 stars
$39.30
-0.3%
$41.60
+5.9%
+53.5%$1.37B$947.71M43.609,700

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 10/3/2026 by MarketBeat.com Staff.
From Our Partners